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A. Katz: The question whether heart failure is an energy- 
deficient state ii quite important. There seems to be a 
disagreement betwzen Drs. Poole-Wilson and Vatner on this 
issue. Dr. Poole-Wilson suggests (on the basis of magnetic 
resonance imaging data) that heart failure probably is not a 
state of energy starvation, but I wonder ifhis measurements 
are biased by the inclusion of epicardial tissue, which would 
be expected to have the least energy deficit. In contrast, Dr. 
Vatner suggests (on the basis of coronary flow measure- 
ments) that here may be an energy deficit in heart failure. I 
wonder if his conclusions are also applicable to pressure 
overload-induced hypertrophy. 
P. Poole-W&on: We cannot extrapolate from data on 
coronary vascular eserve to conclude that there is an 
energy-deficient state in heart failure. The data that I showed 
do not support the existence of an energy deficiency. Fur- 
thermore, parients with heart failure rarely show lactate 
production or a reduction i  coronary sinus oxygen or pH or 
symptoms of myocardial ischemia. Frankly, I cannot find 
any evidence for energy deficiency. However, I would agree 
with you that the data do not completely exclude the 
possibility of energy deprivation, but it does not seem to be 
a major factor. You would probably take the opposite view. 
S. Vatner: It is important to point out that an energy 
deficit may not be apparent in patients studied under basal 
conditions but may become apparent under stress, such as 
exercise. 
C. Leierz Dr. Vatner, in your pacing model of heart 
failure, did you look at the effects of beta-adrenergic block- 
ade on coronary reserve, as you did in your model of 
hypertrophy? 
S. Vatner: No, we have not done that yet, because we 
were able to completely eliminate the changes in coronary 
reserve in the pacing model by changing the !oading condi- 
tions. 
C. L&r: Can you speculate on why beta-blockade may 
improve coronary reserve in the hypertrophy model? 
S. Vatmer: In that model we think that the response to 
exercise causes major increases in diastolic and systolic 
stress, along with changes in contractility and heart rate. 
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Therefore, the increases in oxygen demand of the heart were 
very great and the flow reserve was not able to meet hese 
increased emands. By pretreating the animals with beta- 
blockers, we were able to attenuate he increases indemand 
and thereby diminish the need for coronary flow, SO that 
even with impaired reserve the heart was able to maintain its 
flow in the subendocardial layers in response to stress. 
B. Pitt: I assume that beta-blockers were given as short- 
term therapy in these studies, not as long-term therapy. 
S. Vatner: Yes. 
B. Pitt: Furthermore, you did not alter left ventricular 
hypertrophy in these experiments; you just altered the 
stress. 
S. Vatner: Yes. ne same animals were studied on 2 
separate days. 
M. Sole: Dr. Schwartz, you performed your studies in 
models of maladaptive myocardial hypertrophy. Do you see 
the same sort of mechanogenic transduction i  models of 
adaptive hypertrophy, such as shunt models or anemic 
models? 
K. Sebwartz We have done little work in such models. 
However, in a model of aortacaval fistula (which yielded 
considerable hypertrophy), the extent of the changes was 
quite diverent from what we observed in pressure overload. 
However, I do not know which changes are adaptive and 
which are maladaptive. 
M. Packer: Dr. Poole-Wilson claims that the real differ- 
ence between heart failure and asymptomatic left ventricular 
dysfunction is the presence ofsodium retention. Simply put, 
if patients did not have sodium retention, they would not 
have heart fuilm. Does that mean that if we treat patients 
with heart failure with diuretic drugs vigorously enough to 
rid them of sodium retention, then we will have cured them 
of heart failure? 
P. Pode-Win: No. It is a semantic poiilt. i agree that 
some patients have an abnormally fimctioaing heart and 
have symptoms on exercise, but they do riot have fluid 
retention and are not receiving diuretic drugs. I call that 
condition left ventricular dysfunction. If 3uid retention, past 
or present, exists, then I refer to the condit:on a? heart 
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failure. In our epidemiologic studies in Londca, we found it 
particularly us&d to identify heart failure by three features. 
1) There is an abnormality of the heart; 2) the patient has 
symptoms; and 3) a doctor has prescribed diuretic drugs for 
heart failure with benefit. The combination of all three 
features constitutes a very tough definition of heart failure, 
but it is a definition that is very easy to use in epidemiologic 
studies. 
M. mer: I think that many patients with severe heart 
failure have normal plasma volumes and cormal values for 
total body sodium. 
P. ParItz-WiKom Do you have data on that? 
M. Pucker: Some of the patients treated with diuretic 
drugs in your own series and in other published studies 
provide the data we are talking about. 
P. PeoIeWIIsom It depends on whether or not the patients 
are treated. If they are treated, our data show very clearly 
that the volumes return to normal. 
M. Packer: Exactly. Such patients are very disabled and 
have severe xercise intolerance. They have a high risk of 
hospitalization a d death. Therefore, they fulfI0 all of the 
definitions of severe heart failure. 
Dr. Schwartz, you showed that isoform switches are a 
common occurrence with the onset of hypertrophy orheart 
failure. Such switches represent a reversion from an adult o 
a fetal isoform, presumably in an effort to enhance the 
efliciency of the cell or organ. My questions are: Why is the 
fetal isoform more efficient? Why is there a shift from an 
efiicient to an inefiicient state when people grow up? 
K. Schwartz: I do not know. When you change from one 
physiologic state to another, the heart expresses the genetic 
program that produces the best adaptation. Yet, I am not 
convinced that things are so simple because this concept 
cannot explain why there is a reversal to a fetal isoform. One 
hypothesis i  that he working condition of the fetal heart is 
similar to that of the overloaded adult heart, perhaps be- 
cause both represent hypoxic onditions. 
P. PooIe-WI Most of the changes occur in small 
hearts of small animals or small humans. Once you get to 
middle age, say to the age of 30 years, with a full-sized adult 
human heart, the changes are not so great. The interesting 
question is: What changes are occurring in old age? 
K. Schwartz You are right that the changes that occur 
during normal growth seem to occur after birth. In contrast, 
the senescent heart is similar to the overloaded heart. The 
work of Anversa et al. has shown that there is loss of 
myocyte during aging: which results in hypertrophy of the 
remaining myocytes. So it may be that aging produces a
mechanical overload on the remaining myocytes, which 
results in changes in gene expression resembling the over- 
loaded heart. 
J. Burnett: You have stressed very importantly the mech- 
anogenic mechanism of hypertrophy. What is the relevance 
of either paracrine or circulating factors in activating these 
fetal proteins and gene programs? 
K. S&war@ I think the paracrine or circulating factors 
have a very important place. When I say mechanical, I mean 
that the stretch affects endothelial cells that trigger a para- 
crine mechanism that acts upon the myocyte. Yet it is also 
known that stretch on myocyte can produce changes ingene 
expression directly. It is a very complex siruation. 
